-
Je něco špatně v tomto záznamu ?
IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe
RP. Steeds, D. Messika-Zeitoun, J. Thambyrajah, A. Serra, E. Schulz, J. Maly, M. Aiello, TK. Rudolph, G. Lloyd, AS. Bortone, A. Clerici, G. Delle-Karth, J. Rieber, C. Indolfi, M. Mancone, L. Belle, A. Lauten, M. Arnold, BJ. Bouma, M. Lutz, C....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2014
Freely Accessible Journals
od 2014
PubMed Central
od 2014
Europe PubMed Central
od 2014
ProQuest Central
od 2014-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2014-01-01
Health & Medicine (ProQuest)
od 2014-01-01
- MeSH
- aortální chlopeň chirurgie MeSH
- aortální stenóza epidemiologie chirurgie MeSH
- časové faktory MeSH
- hodnocení rizik metody MeSH
- incidence MeSH
- lidé MeSH
- následné studie MeSH
- registrace * MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- sexuální faktory MeSH
- srdeční chlopně umělé * MeSH
- stupeň závažnosti nemoci MeSH
- transkatetrální implantace aortální chlopně metody MeSH
- věkové faktory MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
AIMS: There is an increasing awareness of gender-related differences in patients with severe aortic stenosis and their outcomes after surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI). METHODS: Data from the IMPULSE registry were analysed. Patients with severe aortic stenosis (AS) were enrolled between March 2015 and April 2017 and stratified by gender. A subgroup analysis was performed to assess the impact of age. RESULTS: Overall, 2171 patients were enrolled, and 48.0% were female. Women were characterised by a higher rate of renal impairment (31.7 vs 23.3%; p<0.001), were at higher surgical risk (EuroSCORE II: 4.5 vs 3.6%; p=0.001) and more often in a critical preoperative state (7.0vs 4.2%; p=0.003). Men had an increased rate of previous cardiac surgery (9.4 vs 4.7%; p<0.001) and a reduced left ventricular ejection fraction (4.9 vs 1.3%; p<0.001). Concomitant mitral and tricuspid valve disease was substantially more common among women. Symptoms were highly prevalent in both women and men (83.6 vs 77.3%; p<0.001). AVR was planned in 1379 cases. Women were more frequently scheduled to undergo TAVI (49.3 vs 41.0%; p<0.001) and less frequently for SAVR (20.3 vs 27.5%; p<0.001). CONCLUSIONS: The present data show that female patients with severe AS have a distinct patient profile and are managed in a different way to males. Gender-based differences in the management of patients with severe AS need to be taken into account more systematically to improve outcomes, especially for women.
4th Medical Department Hietzing Hospital Vienna Austria
Cardiology Department AKH Celle Celle Germany
Centre Hospital d'Annecy Annecy France
Department for Cardiology Helios Erfurt Clinic Erfurt Germany
Department of Cardiology and Angiology University of Kiel Kiel Germany
Department of Cardiology University of Erlangen Erlangen Germany
Department of Cardiothoracic Surgery Foundation IRCCS Policlinico S Matteo Pavia Italy
Division of Cardiology and URT CNR of IFC University Magna Graecia Catanzaro Italy
Edwards Lifesciences Nyon Switzerland
Edwards Lifesciences Prague Czech Republic
Herzkatheterlabor Nymphenburg and Department of Cardiology University of Munich Munich Germany
Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
Interventional Cardiology Unit Hospital de la Santa Creu i Sant Pau Barcelona Spain
James Cook University Hospital Middlesbrough UK
Sapienza University of Rome Rome Italy
St Bartholomew's Hospital London UK
University of Amsterdam Amsterdam Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026301
- 003
- CZ-PrNML
- 005
- 20211026133020.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/openhrt-2020-001443 $2 doi
- 035 __
- $a (PubMed)33419934
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Steeds, Richard Paul $u Queen Elizabeth Hospital & Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
- 245 10
- $a IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe / $c RP. Steeds, D. Messika-Zeitoun, J. Thambyrajah, A. Serra, E. Schulz, J. Maly, M. Aiello, TK. Rudolph, G. Lloyd, AS. Bortone, A. Clerici, G. Delle-Karth, J. Rieber, C. Indolfi, M. Mancone, L. Belle, A. Lauten, M. Arnold, BJ. Bouma, M. Lutz, C. Deutsch, J. Kurucova, M. Thoenes, P. Bramlage, N. Frey, IMPULSE registry group
- 520 9_
- $a AIMS: There is an increasing awareness of gender-related differences in patients with severe aortic stenosis and their outcomes after surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI). METHODS: Data from the IMPULSE registry were analysed. Patients with severe aortic stenosis (AS) were enrolled between March 2015 and April 2017 and stratified by gender. A subgroup analysis was performed to assess the impact of age. RESULTS: Overall, 2171 patients were enrolled, and 48.0% were female. Women were characterised by a higher rate of renal impairment (31.7 vs 23.3%; p<0.001), were at higher surgical risk (EuroSCORE II: 4.5 vs 3.6%; p=0.001) and more often in a critical preoperative state (7.0vs 4.2%; p=0.003). Men had an increased rate of previous cardiac surgery (9.4 vs 4.7%; p<0.001) and a reduced left ventricular ejection fraction (4.9 vs 1.3%; p<0.001). Concomitant mitral and tricuspid valve disease was substantially more common among women. Symptoms were highly prevalent in both women and men (83.6 vs 77.3%; p<0.001). AVR was planned in 1379 cases. Women were more frequently scheduled to undergo TAVI (49.3 vs 41.0%; p<0.001) and less frequently for SAVR (20.3 vs 27.5%; p<0.001). CONCLUSIONS: The present data show that female patients with severe AS have a distinct patient profile and are managed in a different way to males. Gender-based differences in the management of patients with severe AS need to be taken into account more systematically to improve outcomes, especially for women.
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a aortální chlopeň $x chirurgie $7 D001021
- 650 _2
- $a aortální stenóza $x epidemiologie $x chirurgie $7 D001024
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 12
- $a srdeční chlopně umělé $7 D006350
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $x metody $7 D018570
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a sexuální faktory $7 D012737
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a transkatetrální implantace aortální chlopně $x metody $7 D065467
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Messika-Zeitoun, David $u University of Ottawa Heart Institute, Ottawa, Ontario, Canada
- 700 1_
- $a Thambyrajah, Jeetendra $u James Cook University Hospital, Middlesbrough, UK
- 700 1_
- $a Serra, Antonio $u Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- 700 1_
- $a Schulz, Eberhard $u Cardiology Department, AKH Celle, Celle, Germany
- 700 1_
- $a Maly, Jiri $u Department of Cardiovascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Cardiovascular Surgery, Second Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Aiello, Marco $u Department of Cardiothoracic Surgery, Foundation IRCCS Policlinico S.Matteo, Pavia, Italy
- 700 1_
- $a Rudolph, Tanja K $u Department of Cardiology, Heart and Diabetes Center Bad Oeynhausen, Ruhr-University of Bochum, Bad Oeynhausen, Germany
- 700 1_
- $a Lloyd, Guy $u St Bartholomew's Hospital, London, UK
- 700 1_
- $a Bortone, Alessandro Santo $u University of Bari, Bari, Italy
- 700 1_
- $a Clerici, Alberto $u University of Turin, Turin, Italy
- 700 1_
- $a Delle-Karth, Georg $u 4th Medical Department, Hietzing Hospital, Vienna, Austria
- 700 1_
- $a Rieber, Johannes $u Herzkatheterlabor Nymphenburg and Department of Cardiology, University of Munich, Munich, Germany
- 700 1_
- $a Indolfi, Ciro $u Division of Cardiology and URT CNR of IFC, University Magna Graecia, Catanzaro, Italy
- 700 1_
- $a Mancone, Massimo $u Sapienza University of Rome, Rome, Italy
- 700 1_
- $a Belle, Loic $u Centre Hospital d'Annecy, Annecy, France
- 700 1_
- $a Lauten, Alexander $u Department for Cardiology, Helios Erfurt Clinic, Erfurt, Germany
- 700 1_
- $a Arnold, Martin $u Department of Cardiology, University of Erlangen, Erlangen, Germany
- 700 1_
- $a Bouma, Berto J $u University of Amsterdam, Amsterdam, Netherlands
- 700 1_
- $a Lutz, Matthias $u Department of Cardiology and Angiology, University of Kiel, Kiel, Germany
- 700 1_
- $a Deutsch, Cornelia $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
- 700 1_
- $a Kurucova, Jana $u Edwards Lifesciences, Prague, Czech Republic
- 700 1_
- $a Thoenes, Martin $u Edwards Lifesciences, Nyon, Switzerland
- 700 1_
- $a Bramlage, Peter $u Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany peter.bramlage@ippmed.de
- 700 1_
- $a Frey, Norbert $u Department of Cardiology and Angiology, University of Kiel, Kiel, Germany
- 710 2_
- $a IMPULSE registry group
- 773 0_
- $w MED00186378 $t Open heart $x 2053-3624 $g Roč. 8, č. 1 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33419934 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133026 $b ABA008
- 999 __
- $a ok $b bmc $g 1715121 $s 1146808
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 8 $c 1 $e - $i 2053-3624 $m Open heart $n Open Heart $x MED00186378
- LZP __
- $a Pubmed-20211013